Topic
How do you get insurance to cover a GLP-1?
Prior authorization, appeals, employer and Medicaid coverage, and patient assistance, all sourced.
GLP-1 Prior Authorization Requirements: What Insurers Ask ForInsurers approving Wegovy or Zepbound typically require a BMI of 30 or higher (27 with a comorbidity), documented participation in a weight management program, and proof of at least 5% weight loss at renewal. Exact rules vary by plan and change often.How to Appeal a Zepbound Denial: Steps, Deadlines, and Your OddsIf your insurer denied Zepbound or another GLP-1, appeal through the plan first, then external review — a written request within 4 months. Among Medicare Advantage denials appealed in 2024, 80.7% were overturned, though only 11.5% were appealed at all.How to Get Wegovy Covered by Insurance (and What to Do If It Says No)Coverage for Wegovy and Zepbound is decided by your plan's formulary and prior-authorization rules, not your prescriber. In 2026, 7% of commercially insured people — nearly 13 million — have no coverage for any weight-loss GLP-1, and 88% of those with coverage face added requirements.Is Wegovy HSA Eligible? Paying for GLP-1 Drugs With HSA or FSA FundsYes. Wegovy, Zepbound, Ozempic and other GLP-1s can be paid from an HSA or FSA when prescribed to treat a physician-diagnosed disease such as obesity or diabetes. The 2026 HSA limit is $4,400 self-only and $8,750 family; the FSA limit is $3,400.Medicaid GLP-1 Coverage by State in 2026Thirteen state Medicaid programs covered GLP-1s for obesity as of January 2026, down from 16 in October 2025. Every state still covers them for type 2 diabetes, and Massachusetts and Rhode Island are the latest states moving to drop weight-loss coverage.Medicare GLP-1 Bridge Program Eligibility and CostsThe Medicare GLP-1 Bridge runs July 1, 2026 through December 31, 2027 and gives eligible Part D beneficiaries certain GLP-1 weight-loss drugs for a $50 copay per monthly fill. Eligibility requires age 18 or older, an eligible Part D plan type, and BMI criteria met when GLP-1 therapy started.Novo Nordisk Patient Assistance Program: Wegovy and Lilly CaresFree GLP-1 medicine through a manufacturer program is real but narrow. Novo Nordisk's PAP gives free medicine only to Medicare or uninsured patients under income limits of 200%–400% of the federal poverty level, while Lilly Cares' current lists include Trulicity but not Zepbound or Mounjaro.Which Employers Cover GLP-1s for Weight Loss?No public list names the employers that cover Wegovy or Zepbound, but surveys show coverage ranges from nearly one-fifth of firms with more than 200 workers to 67% of large Business Group on Health members, and a growing share of employers are dropping or restricting coverage heading into 2027. Here is what the data show and how to check your own plan.